Neurochemical dissection of synaptic pathology in Alzheimer's disease

International Psychogeriatrics

Volumn 10, Issue 1, 1998, Pages 11-23

  Davidsson, Pia ^a   Blennow, Kaj ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROGRANIN; NEUROMODULIN; RAB PROTEIN; SYNAPTOPHYSIN; SYNAPTOTAGMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MULTIINFARCT DEMENTIA; NEUROCHEMISTRY; ONSET AGE; PRESYNAPTIC MEMBRANE; SYNAPSE VESICLE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CEREBELLUM; DEMENTIA, VASCULAR; FRONTAL LOBE; GTP-BINDING PROTEINS; HIPPOCAMPUS; HUMANS; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; PRESYNAPTIC TERMINALS; SENILE PLAQUES; SEVERITY OF ILLNESS INDEX; SYNAPSES; SYNAPTIC MEMBRANES; SYNAPTIC VESICLES;

EID: 0031778614     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610298005110     Document Type: Article

References (52)

1. Adolfsson, R., Gottfries, C. G., Nyström, L., & Winblad, B. (1981). Prevalence of dementia in institutionalised Swedish old people: The work load imposed by caring for these patients. Acta Psychiatrica Scandinavica, 63, 225-244.
2. Alafuzoff, I., Iqbal, K., Fridén, H., Adolfsson, R., & Winblad, B. (1987). Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathologica (Berlin), 74, 209-225.
3. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology, 4, 631-639.
4. Basi, G. S. (1987). Primary structure and transcriptional regulation of GAP-43, a protein associated with nerve growth. Cell, 49, 785-791.
5. Benowitz, L. I., Perrone-Bizzozero, N. I., Finklestein, S. P., & Bird, E. D. (1989). Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human cerebral cortex. Journal of Neuroscience, 9, 990-995.
6. Blennow, K., Bogdanovic, N., Alafuzoff, I., Ekman, R., & Davidsson, P. (1996). Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the apoE4 allele. Journal of Neural Transmission (Parkinson's Disease and Dementia Section), 103, 603-618.
7. Blennow, K., Wallin, A., & Gottfries, C. G. (1991). Presence of parietal lobe symptomatology distinguishes early and late onset Alzheimer's disease. International Journal of Geriatric Psychiatry, 6, 147-154.
8. Brose, N., Petrenko, A. G., Südhof, T. C., & Jahn, R. (1992). Synaptotagmin, a Ca++ sensor on the synaptic vesicle surface. Science, 256, 1021-1025.
9. Coleman, P. D., & Flood, D. G. (1987). Neuron numbers and dendrite extent in normal aging and Alzheimer's disease. Neurobiology of Aging, 8, 521-545.
10. Coleman, P. D., Kazee, A. M., Lapham, L., Eskin, T., & Rogers, K. (1992). Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer's disease. Neurobiology of Aging, 13, 631-639.
11. Constantinidis, J. (1978). Is Alzheimer's disease a major form of senile dementia? Clinical, anatomical and genetic data. In R. Katzman, R. D. Terry, & K. L. Bick (Eds.), Alzheimer's disease: Senile dementia and related disorders (Aging, Vol. 7, pp. 15-25). New York: Raven Press.
12. DeKosky, S. T., & Scheff, S. W. (1990). Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with disease severity. Annals of Neurology, 27, 457-464.
13. De la Monte, S. M., Ng, S. C., & Hsu, D. W. (1995). Aberrant GAP-43 gene expression in Alzheimer's disease. American Journal of Pathology, 147, 934-946.
14. Dickson, D. W., Crystal, H. A., Benova, C., Honer, W., Vincent, I., et al. (1995). Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiology of Aging, 16, 285-304.
15. Erkinjuntti, T., & Hachinski, V. C. (1993). Rethinking vascular dementia. Cerebrovascular Dissociation, 3, 3-23.
16. Fischer von Mollard, G., Mignery, G. A., Baumert, M., Burger, P. R., Perin, M., et al. (1991). Rab 3a is a small GTP-binding protein exclusively localized to synaptic vesicles. Proceedings of the National Academy of Sciences of the United States of America, 87, 1988-1992.
17. Gispen, W. H., Leunissen, J. L. M., Oestreicher, A. B., Verkleij, A. J., & Zweirs, H. (1985). Presynaptic localization of B-50 phosphoprotein: The (ACTH)-sensitive protein kinase substrate involved in rat brain polyphosphoinositide metabolism. Brain Research, 328, 381-385.
18. Hardy, J., & Allsop, D. (1991). Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends in Pharmacology Science, 12, 383-388.
19. Heinonen, O., Soininen, H., Sorvari, H., Kosunen, O., Paljärvi, L., et al. (1995). Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience, 64, 375-384.
20. Honer, W. G., Dickson, D. W., Gleeson, J., & Davies, P. (1992). Regional synaptic pathology in Alzheimer's disease. Neurobiology of Aging, 13, 375-382.
21. Jahn, R., Schiebler, W., Quimet, C., & Greengard, P. (1985). A 38,000 dalton membrane protein (p38) present in synaptic vesicles. Proceedings of the National Academy of Sciences of the United States of America, 82, 4137-4141.
22. Jahn, R., & Südhof, T. C. (1993). Synaptic vesicle traffic: Rush hour in the nerve terminal. Journal of Neurochemistry, 61, 12-21.
23. Karns, L. R., Ng, S. C., Freeman, J. A., & Fishman, M. C. (1987). Cloning of complementary DNA for GAP-43, a neuronal growth-related protein. Science, 236, 822-827.
24. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature, 227, 680-685.
25. Lassman, H., Weiler, R., Fischer, P., Bancher, C., Jellinger, K., et al. (1992). Synaptic pathology in Alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles. Neuroscience, 46, 1-8.
26. Lauter, H. (1970). Über Spätformen der Alzheimerschen Krankheit und ihre Beziehung zur senilen [The presenile form of Alzheimer's disease and its relation to dementia]. Demenzia Psychiatry Clinica, 3, 169-189.
27. Leary, J. J., Brigati, D. J., & Ward, D. C. (1983). Rapid and sensitive colorimetric method for visualising biotin-labelled DNA probes hybridized to DNA or RNA immobilized in nitrocellulose: Bio-blots. Proceedings of the National Academy of Sciences of the United States of America, 80, 4045-4049.
28. Mann, D. M. A., Yates, P. O., & Marcyniuk, B. (1985). Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. Journal of the Neurological Sciences, 69, 139-159.
29. Masliah, E., Hansen, L., Albright, T., Mallory, M., & Terry, R. D. (1991a). Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathologica, 81, 428-433.
30. Masliah, E., Mallory, M., Hansen, L., Alford, M., Albright, T., et al. (1991b). Patterns of aberrant sprouting in Alzheimer's disease. Neuron, 6, 729-739.
31. Masliah, E., Terry, R. D., Alford, M., DeTeresa, R., & Hansen, L. A. (1991c). Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. American Journal of Pathology, 138, 235-246.
32. Matteoli, M., Takei, K., Cameron, R., Hurlkbut, P., Johnston, P. A., et al. (1991). Association of rab3a with synaptic vesicles at late stages of the secretory pathway. Journal of Cell Biology, 11, 625-633.
33. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., et al. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group Under Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
34. Mercken, M., Lübke, U., Vandermeeren, M., Gheuens, J., & Oestreicher, A. B. (1992). Immunocytochemical detection of the growth-associated protein B-50 by newly characterized monoclonal antibodies in human brain and muscle. Journal of Neurobiology, 23, 309-321.
35. Mirra, S. S., Heyman, A., & McKeel, D. (1991). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 14, 479-486.
36. Perin, M. S., Fried, V. A., Mignery, G. A., Jahn, R., & Südhof, T. C. (1990). Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C. Nature, 345, 260-263.
37. Roth, M. (1980). Perspectives in the scientific study of mental illness in old age. In M. Lader (Ed.), Priorities in psychiatric research (pp. 91-114). Chichester, England: John Wiley & Sons.
38. Roth, M. (1986). The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease. British Medical Bulletin, 42, 42-50.
39. Scheltens, P., Barkhof, F., Valk, J., et al. (1992). White matter lesions on magnetic resonance imaging in Alzheimer's disease: Evidence for heterogeneity. Brain, 115, 735-748.
40. Selkoe, D. J. (1994). Alzheimer's disease: A central role for amyloid. Journal of Neuropathology and Experimental Neurology, 53, 438-447.
41. Skene, J. H. P., & Willard, M. (1981). Changes in axonally transported proteins during axon regeneration and toad retinal ganglion cells. Journal of Cell Biology, 89, 86-95.
42. Skoog, I. (1994). Risk factors for vascular dementia. A review. Dementia, 5, 137-144.
43. Südhof, T., & Jahn, R. (1991). Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron, 6, 665-667.
44. Südhof, T. C., DeCamilli, P., Niemann, H., & Jahn, R. (1993). Membrane fusion machinery; Insights from synaptic proteins. Cell, 75, 1-4.
45. Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., et al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30, 572-580.
46. Tomlinson, B. E., & Corsellis, J. A. N. (1984). Ageing and the dementias. In J. Hume Adams, J. A. N. Corsellis, & L. W. Duchen (Eds.), Greenfield's neuropathology (pp. 951-1025). London: Edward Arnold.
47. Tomlinson, B. E., & Henderson, G. (1976). Some quantitative cerebral findings in normal and demented old people. In R. D. Terry & S. Gershon (Eds.), Neurobiology of aging (pp. 183-204). New York: Raven Press.
48. Walch-Solimena, C., Takei, K., Marek, K. L., Midyett, K., Südhof, T. C., et al. (1993). Synaptotagmin: A membrane constituent of neuropeptide-containing large dense core vesicles. Journal of Neuroscience, 13, 3895-3903.
49. Wallin, A., & Blennow, K. (1991). The pathogenetic basis of vascular dementia. Alzheimer Disease and Associated Disorders, 5, 91-102.
50. Watson, J. B., Szijan, I., & Coulter, P. M. II (1994). Localization of RC3 (neurogranin) in rat brain subcellular fractions. Molecular Brain Research, 27, 323-328.
51. Wilcock, G. K., & Esiri, M. M. (1982). Plaques, tangles and dementia: A quantitative study. Journal of Neurological Sciences, 56, 343-356.
52. Zhan, S. S., Beyreuther, K., & Schmitt, H. P. (1994). Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. Dementia, 5, 79-87.